CASI (CASIF) General Counsel discloses vested and performance-based stock options
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
CASI Pharmaceuticals, Inc. General Counsel Wei R Gao filed a Form 3 reporting existing holdings of stock options on the company’s ordinary shares. The filing lists multiple options to buy shares at exercise prices of $1.93, $2.67, and $5.78 per share with expirations between 2031 and 2034. Footnotes state that these options are fully vested and exercisable as of the filing date, and some are performance-based options that become exercisable upon achieving a specified performance target.
Positive
- None.
Negative
- None.
Insider Trade Summary
13 transactions reported
Mixed
13 txns
Insider
Gao Wei R
Role
General Counsel
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
Holdings After Transaction:
Option (right to buy) — 4,000 shares (Direct)
Footnotes (1)
- The options are fully vested and exercisable as of the date of this form. Performance based options exercisable upon achievement of performance target.
Key Figures
Exercise price: $1.93 per share
Exercise price: $2.67 per share
Exercise price: $5.78 per share
+5 more
8 metrics
Exercise price
$1.93 per share
Stock options on CASI ordinary shares
Exercise price
$2.67 per share
Stock options on CASI ordinary shares
Exercise price
$5.78 per share
Stock options on CASI ordinary shares
Underlying shares
25,000 shares
Options expiring on 2034-11-06 at $5.78
Underlying shares
10,000 shares
Options expiring on 2034-11-06 at $5.78
Underlying shares
8,000 shares
Options expiring on 2033-05-12 at $1.93
Earliest expiration
2031-06-18
Options at $1.93 per share
Latest expiration
2034-11-06
Options at $5.78 per share
Key Terms
Option (right to buy, Ordinary Share, fully vested and exercisable, Performance based options
4 terms
Option (right to buy financial
"security_title": "Option (right to buy)"
fully vested and exercisable financial
"The options are fully vested and exercisable as of the date"
Performance based options financial
"Performance based options exercisable upon achievement of performance target"
FAQ
What does the CASI (CASIF) Form 3 filing by Wei R Gao show?
The Form 3 shows that CASI General Counsel Wei R Gao holds various stock options on ordinary shares with exercise prices of $1.93, $2.67, and $5.78, expiring between 2031 and 2034, many of which are already fully vested and exercisable.
What stock option terms are disclosed for CASI (CASIF) General Counsel Wei R Gao?
The filing discloses options to buy CASI ordinary shares at exercise prices of $1.93, $2.67, and $5.78 per share. These options have expiration dates ranging from 2031-06-18 to 2034-11-06 and cover multiple blocks of underlying ordinary shares.
Are Wei R Gao’s CASI (CASIF) options already vested and exercisable?
According to a footnote, the options are fully vested and exercisable as of the date of the form. Another footnote explains that certain awards are performance-based options that become exercisable only upon achievement of a defined performance target by CASI Pharmaceuticals.
What are the largest CASI (CASIF) option blocks reported by Wei R Gao?
The Form 3 lists several option grants, including blocks covering 25,000 and 10,000 underlying ordinary shares at an exercise price of $5.78 per share, expiring on 2034-11-06, alongside multiple smaller grants at exercise prices of $1.93 and $2.67 per share.
What does a Form 3 like CASI (CASIF) General Counsel’s filing indicate to investors?
A Form 3 provides an initial snapshot of an insider’s existing holdings when they become a reporting person. In CASI’s case, it outlines Wei R Gao’s stock option positions, helping investors understand the scale, pricing, and vesting conditions of the General Counsel’s equity-based incentives.